Anne E Bendel MD

Pediatric Hematology & Oncology•Minneapolis, MN

Physician

Join to View Full Profile

2525 Chicago Ave SChildrens Specialty Clinic Hematology Oncology MplsMinneapolis, MN 55404
Phone+1 612-813-5940
Fax+1 612-813-6325

Education & Training

University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1990 - 1993
University of MinnesotaResidency, Pediatrics, 1987 - 1990
University of Minnesota Medical SchoolClass of 1987

Certifications & Licensure

MN State Medical License 1990 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Top MD Consumers Checkbook

Clinical Trials

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma Start of enrollment: 2007 Dec 17
ACTIVE_NOT_RECRUITING
PHASE2
Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) Start of enrollment: 2011 Sep 01
Terminated
Phase 2
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma Start of enrollment: 2013 Jun 23
ACTIVE_NOT_RECRUITING
PHASE2
Laser Interstitial Thermal Therapy (LITT) for the Treatment of Pediatric Central Nervous System Tumors Start of enrollment: 2015 Apr 01
Completed
Not Applicable
REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma Start of enrollment: 2018 Sep 24
TERMINATED
PHASE1, PHASE2
Roles: Contact
Fimepinostat in Treating Brain Tumors in Children and Young Adults Start of enrollment: 2019 Aug 07
ACTIVE_NOT_RECRUITING
EARLY_PHASE1
Roles: Contact
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
ACTIVE_NOT_RECRUITING
PHASE4
Roles: Contact
Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors Start of enrollment: 2014 May 14
ACTIVE_NOT_RECRUITING
PHASE2
Roles: Contact, Principal Investigator
Combination Therapy for the Treatment of Diffuse Midline Gliomas Start of enrollment: 2021 Oct 20
RECRUITING
PHASE2
Roles: Contact
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) Start of enrollment: 2020 Dec 09
RECRUITING
PHASE1
Roles: Contact, Principal Investigator
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma Start of enrollment: 2022 Dec 20
RECRUITING
PHASE2
Roles: Principal Investigator, Contact
CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults Start of enrollment: 2024 Mar 15
Recruiting
Phase 1
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.
Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, Elke Pfaff, Pouneh Amir-Yazdani
Clinical Cancer Research. 2025-02-03
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip.
John J Y Lee, Ran Tao, Zhen You, Parthiv Haldipur, Anders W Erickson
Nature Genetics. 2025-01-01
12 citations
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
Ayse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, Yuan Chang, Adrian Levine
The Lancet. Oncology. 2024-05-01

Press Mentions

Top Doctors 2022: Delivering Better OutcomesJuly 17th, 2022
Top Doctors 2022: Delivering Better OutcomesJuly 17th, 2022
Top Doctors 2022: Delivering Better OutcomesJuly 17th, 2022
Join now to see all

Anne E Bendel MD

Dr. Bendel is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.